2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure …
JW McEvoy, CP McCarthy, RM Bruno… - European Heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Management of hypertension in patients with cancer: challenges and considerations
S Pandey, A Kalaria, KD Jhaveri… - Clinical Kidney …, 2023 - academic.oup.com
The survival rates of many cancers have significantly improved due to recent advancements
in cancer screening and therapeutics. Although better cancer outcomes are encouraging …
in cancer screening and therapeutics. Although better cancer outcomes are encouraging …
[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Resistant hypertension: consensus document from the Korean society of hypertension
Although reports vary, the prevalence of true resistant hypertension and apparent treatment-
resistant hypertension (aTRH) has been reported to be 10.3% and 14.7%, respectively. As …
resistant hypertension (aTRH) has been reported to be 10.3% and 14.7%, respectively. As …
Arterial Stiffness: From Basic Primers to Integrative Physiology
V Regnault, P Lacolley, S Laurent - Annual Review of …, 2024 - annualreviews.org
The elastic properties of conductance arteries are one of the most important hemodynamic
functions in the body, and data continue to emerge regarding the importance of their …
functions in the body, and data continue to emerge regarding the importance of their …
Acute reperfusion treatment and secondary prevention of cancer-related stroke: comprehensive overview and proposal of clinical algorithm
AM Aloizou, L Palaiodimou, D Aloizou… - Therapeutic …, 2023 - journals.sagepub.com
Cancer-related stroke (CRS), referring to ischemic stroke occurring in cancer patients
without other clear etiology, represents a clinical challenge, as it is associated with …
without other clear etiology, represents a clinical challenge, as it is associated with …
Effect of renin-angiotensin-aldosterone system inhibitors on survival outcomes in cancer patients treated with immune checkpoint inhibitors: A systematic review and …
J Shen, H Hou, B Liang, X Guo, L Chen… - Frontiers in …, 2023 - frontiersin.org
Background Effect of renin-angiotensin-aldosterone system inhibitors (RAASIs) in
combination with immune checkpoint inhibitors (ICIs) on prognoses in cancer patients …
combination with immune checkpoint inhibitors (ICIs) on prognoses in cancer patients …
Cardiovascular complications of pan-cancer therapies: the need for cardio-oncology
M Chen, J Xue, M Wang, J Yang, T Chen - Cancers, 2023 - mdpi.com
Simple Summary Worldwide, with the steady progress of pan-cancer therapy, the long-term
survival of cancer patients has increased. Inevitably, along with improved life expectancy …
survival of cancer patients has increased. Inevitably, along with improved life expectancy …
Onco-hypertension: a continuously developing field between cancer and hypertension
The prognosis of cancer patients has greatly improved in the last years, owing to the
development of novel chemotherapeutic agents. However, this progress comes with an …
development of novel chemotherapeutic agents. However, this progress comes with an …